ArticleBMC cancer2022

Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy.

Michelle W Wong-Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.